VON ESCHENBACH ANDREW C. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$134,764.70
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of VON ESCHENBACH ANDREW C.

According to the SEC Form 4 filings, VON ESCHENBACH ANDREW C., being in a position of

  1. director at Bausch + Lomb Corporation,
    оver the last 12 months, has bought 4364 shares for $79,883, and sold 18559 shares for $306,708,
    over all time since 2025-05-02, has bought 6059 shares for $99,808, and sold 18559 shares for $306,708.

Biography of VON ESCHENBACH ANDREW C.

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$79,883133
Sells
$306,708267

Comparison of Insiders on Amount of Buys and Sells

2026-08-07SaleBausch + Lomb Corporation
BLCO
director
6,059
0.0017%
$16.58$100,458+2.38%
2026-08-06SaleBausch + Lomb Corporation
BLCO
director
12,500
0.0035%
$16.50$206,250+5.05%
2026-02-27PurchaseBausch + Lomb Corporation
BLCO
director
4,364
0.0012%
$18.30$79,883-9.29%
2025-05-02PurchaseBausch + Lomb Corporation
BLCO
director
1,695
0.0005%
$11.76$19,925+33.3%
2021-08-05PurchaseBausch Health Companies Inc.
BHC
director
2,800
0.0008%
$25.94$72,632-6.04%
2020-03-10PurchaseBausch Health Companies Inc.
BHC
director
2,200
0.0006%
$18.18$39,993-6.17%
2013-08-12PurchaseLineage Cell Therapeutics, Inc.
LCTX
director
6,000
0.0108%
$3.69$22,140-4.32%
Total: 7
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.